Skip to main content
. 2022 Feb 15;49(3):381–394. doi: 10.1007/s10928-021-09799-0

Table 4.

Population pharmacokinetics parameter estimates from final semi-mechanistic model

Fixed effects Standard deviation of the random effect, ωp (RSE%) Residual error (RSE%)
Parameter Estimate (RSE%)
FDAR8 (%) 0.9 (fixed) a aADC (µg/mL) = 1.03 (6)
FDAR7 (%) 2.8 (fixed) 0.272 (fixed) bADC = 8.9% (3)
FDAR6 (%) 7.1 (fixed) 0.132 (fixed) bDM4 = 33.5% (2)
FDAR5 (%) 14.2 (fixed) 0.102 (fixed) bMeDM4 = 50.0% (2)
FDAR4 (%) 19.9 (fixed) 0.059 (fixed) bNAB = 26.0% (2)
FDAR3 (%) 21.8 (fixed) 0.066 (fixed) aDARaverage = 0.219 (6)
FDAR2 (%) 17.5 (fixed) 0.091 (fixed) aDAR7proportion(%) = 0.517 (9)
FDAR1 (%) 8.5 (fixed) 0.091 (fixed) aDAR6proportion(%) = 0.798 (7)
FNAB (%) 7.1 (3) 0.418 (7) aDAR5proportion(%) = 1.47 (7)
CLADC (L/day) 0.392 (3) 0.469 (5) aDAR4proportion(%) = 2.53 (7)
Vc (L) 3.37 (2) 0.245 (5) aDAR3proportion(%) = 3.26 (8)
Q (L/day) 0.543 (5) 0.529 (8) aDAR2proportion(%) = 3.48 (8)
Vp (L) 2.54 (5) 0.605 (8) aDAR1proportion(%) = 4.58 (6)
kdec8 (/day) 0.938 (4) 0.202 (8) aNABproportion(%) = 9.93 (6)
kdec7 (/day)
kdec6 (/day)
kdec5 (/day) 0.751 (3)
kdec4 (/day) 0.525 (4)
kdec3 (/day) 0.340 (4)
kdec2 (/day) 0.181 (3)
kdec1 (/day) 0.0565 (2)
CLNAB (L/day) 0.408 (3) 0.345 (6)
CLDM4 (L/day) 240 (3) 0.365 (6)
CLMeDM4 (L/day) 0.256 (5) 0.654 (6)
FRMeDM4 0.0107 (5) 0.723 (5)

aIIV on FDAR8 was back calculated to ensure equilibrium among administered DAR fractions